<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62149">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02006836</url>
  </required_header>
  <id_info>
    <org_study_id>Tongji201201</org_study_id>
    <nct_id>NCT02006836</nct_id>
  </id_info>
  <brief_title>Glycemic Responses to Majia Pomelos in Type 2 Diabetic Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huazhong University of Science and Technology</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of type 2 diabetes (T2DM) is substantially increasing, partially due to the
      inappropriate diets. It is well documented that adherence to a healthy diet can improve
      glycemic control and may reduce glycosylated hemoglobin (HbA1c) levels. Pomelo is one of the
      most widely cultivated and consumed fruits in China. However, substantial scientific data on
      their nutritional compositions of pomelo are not available. The investigators purpose in
      this study is to identify the nutritional value of one type of pomelo named Majia pomelo and
      obtain the information about whether this variety of pomelo is appropriate for diabetic
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>glucose levels</measure>
    <time_frame>9 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>diabetic</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Insulin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>pomelo</intervention_name>
    <arm_group_label>diabetic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  In the diabetes group, it required that their diabetes was controlled (HbA1c â‰¤ 8%) on
             diet with or without metformin.

        Exclusion Criteria:

          -  For both healthy and diabetic volunteers included morbid obesity (BMI &gt; 40 kg/m2),
             pre diabetes, pregnancy, presence of gastroenterological disorders, alimentary tract
             surgery, a history of gastroenteritis in the prior six months, any alcohol intake,
             smoking, taking any medications (except metformin), poorly controlled diabetes (HbA1c
             &gt; 8%) and the presence of chronic diseases (such as bronchial  asthma or rheumatoid
             arthritis) or acute illness (such as upper respiratory tract or urinary tract
             infection)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 9, 2013</lastchanged_date>
  <firstreceived_date>December 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huazhong University of Science and Technology</investigator_affiliation>
    <investigator_full_name>Xuefeng Yu</investigator_full_name>
    <investigator_title>Director of Division of Endocrinology</investigator_title>
  </responsible_party>
  <keyword>glycemic index</keyword>
  <keyword>diabetes</keyword>
  <keyword>pomelo</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
